大鼠肝脏上清液降解尿嘧啶和胸腺嘧啶的合成嘧啶抑制剂

Harold W. Barrett , S.N. Munavalli , Philip Newmark
{"title":"大鼠肝脏上清液降解尿嘧啶和胸腺嘧啶的合成嘧啶抑制剂","authors":"Harold W. Barrett ,&nbsp;S.N. Munavalli ,&nbsp;Philip Newmark","doi":"10.1016/0926-6550(64)90242-7","DOIUrl":null,"url":null,"abstract":"<div><p>We tested the ability of a number of synthetic pyrimidines to inhibit degradation of uracil and thymine by rat-tissue supernatants. Among nine tissues tested, only liver preparations showed significant pyrimidine-degrading activity, and among 46 compounds tested, only 5-substituted uracils, analogs of thymine, showed appreciable inhibition of pyrimidine degradation. Despite their structure, all active compounds were more effective inhibitors of uracil than of thymine degradation; similarly, uracil and thymine showed reciprocal inhibition, but thymine was considerably more effective. It was concluded that inhibition occurred only during the initial reductive step in pyrimidine degradation, that reduction of both uracil and thymine was catalyzed by the same enzyme (dihydrouracil dehydrogenase (4,5-dihydrouracil: NADP oxidoreductase, EC 1.3.1.2)), and that inhibition resulted from substrate competition for the active site on the enzyme.</p></div>","PeriodicalId":100173,"journal":{"name":"Biochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1964-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0926-6550(64)90242-7","citationCount":"26","resultStr":"{\"title\":\"Synthetic pyrimidines as inhibitors of uracil and thymine degradation by rat-liver supernatant\",\"authors\":\"Harold W. Barrett ,&nbsp;S.N. Munavalli ,&nbsp;Philip Newmark\",\"doi\":\"10.1016/0926-6550(64)90242-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>We tested the ability of a number of synthetic pyrimidines to inhibit degradation of uracil and thymine by rat-tissue supernatants. Among nine tissues tested, only liver preparations showed significant pyrimidine-degrading activity, and among 46 compounds tested, only 5-substituted uracils, analogs of thymine, showed appreciable inhibition of pyrimidine degradation. Despite their structure, all active compounds were more effective inhibitors of uracil than of thymine degradation; similarly, uracil and thymine showed reciprocal inhibition, but thymine was considerably more effective. It was concluded that inhibition occurred only during the initial reductive step in pyrimidine degradation, that reduction of both uracil and thymine was catalyzed by the same enzyme (dihydrouracil dehydrogenase (4,5-dihydrouracil: NADP oxidoreductase, EC 1.3.1.2)), and that inhibition resulted from substrate competition for the active site on the enzyme.</p></div>\",\"PeriodicalId\":100173,\"journal\":{\"name\":\"Biochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1964-10-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0926-6550(64)90242-7\",\"citationCount\":\"26\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0926655064902427\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0926655064902427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 26

摘要

我们测试了一些合成嘧啶抑制大鼠组织上清液降解尿嘧啶和胸腺嘧啶的能力。在测试的9种组织中,只有肝脏制剂具有显著的嘧啶降解活性,而在测试的46种化合物中,只有胸腺嘧啶类似物5-取代尿嘧啶具有明显的嘧啶降解抑制作用。尽管它们的结构不同,但所有活性化合物都是尿嘧啶比胸腺嘧啶降解更有效的抑制剂;同样,尿嘧啶和胸腺嘧啶表现出相互抑制,但胸腺嘧啶明显更有效。结果表明,抑制作用仅发生在嘧啶降解的初始还原阶段,尿嘧啶和胸腺嘧啶的还原是由同一酶(二氢尿嘧啶脱氢酶(4,5-二氢尿嘧啶:NADP氧化还原酶,EC 1.3.1.2)催化的,抑制作用是由于底物对酶活性位点的竞争引起的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Synthetic pyrimidines as inhibitors of uracil and thymine degradation by rat-liver supernatant

We tested the ability of a number of synthetic pyrimidines to inhibit degradation of uracil and thymine by rat-tissue supernatants. Among nine tissues tested, only liver preparations showed significant pyrimidine-degrading activity, and among 46 compounds tested, only 5-substituted uracils, analogs of thymine, showed appreciable inhibition of pyrimidine degradation. Despite their structure, all active compounds were more effective inhibitors of uracil than of thymine degradation; similarly, uracil and thymine showed reciprocal inhibition, but thymine was considerably more effective. It was concluded that inhibition occurred only during the initial reductive step in pyrimidine degradation, that reduction of both uracil and thymine was catalyzed by the same enzyme (dihydrouracil dehydrogenase (4,5-dihydrouracil: NADP oxidoreductase, EC 1.3.1.2)), and that inhibition resulted from substrate competition for the active site on the enzyme.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信